Dalroi:
Don't I find it strange?
It is strange. I've been saying that it's strange for many weeks, but it just keeps getting stranger.
I just don't see how, with such light open interest in all options, that it's option-related. That said, why do you hope that Spyros is correct? Do you're assuming that any seller.... say a Wisconsin...... would have more insight than you? Big, big, big, big mistake on >90% of biotech decisions.
A friend says that market makers can short without the short interest showing up at reporting time.
If so, let's see a 2331 license, ASAP. I realize that it might not be as wise as waiting, from a business perspective, but..... it'd sure feel damn good.
Oesterling et al. are sweating over the real-world issues of bringing valuable medicines to the patient. I'm not really interested in discussing volatility and nervous hands..... as opposed to nerves.
Why don't you see if the SEC would be interested in exploring the issues for you? I'm riding for the long-term, and I just don't care about what is happening today. I *am* curious about where these 300K shares have come from, however.
Cheers! Rick |
